- Inequities in kidney health and kidney care(2023)
Auteurs: Raymond Vanholder, Lieven Annemans, Marion Braks, Edwina A. Brown, Priya Pais, Tanjala S. Purnell, Simon Sawhney, Nicole Scholes-Robertson, Benedicte Stengel, Elliot K. Tannor, et al.
Pagina's: 694 - 708
- How biocompatible haemodialysers can conquer the need for systemic anticoagulation even in post-dilution haemodiafiltration : a cross-over study(2021)
Auteurs: Floris Vanommeslaeghe, Iván Josipovic, Matthieu Boone, Arjan van der Tol, Annemieke Dhondt, Wim Van Biesen, Sunny Eloot
Pagina's: 1752 - 1759
- Farmacotherapeutische actualiteit(2020)
Auteurs: Arjan van der Tol, Lucas Van Bortel, Thierry Christiaens
Pagina's: 209 - 211
- A call for harmonization of European kidney care : dialysis reimbursement and distribution of kidney replacement therapies(2020)
Auteurs: Arjan van der Tol, Vianda S Stel, Kitty J Jager, Rachael L Morton, Wim Van Biesen, Raymond Vanholder, [missing] European Kidney Health Alliance (EKHA)
Pagina's: 979 - 986
- An international analysis of dialysis services reimbursement(2019)
Auteurs: Arjan van der Tol, Rachael L Morton, Wim Van Biesen, Raymond Vanholder
Pagina's: 84 - 93
- Pitfalls of using microalbuminuria as a screening tool to identify subjects with increased risk for kidney and cardiovascular disease(2014)
Auteurs: Arjan van der Tol
- Supplemented ERA-EDTA registry data evaluated the frequency of dialysis, kidney transplantation and comprehensive conservative management for patients with kidney failure in Europe
Auteurs: Vianda S. Stel, Rianne W. de Jong, Anneke Kramer, Anton M. Andrusev, José M. Baltar, Myftar Barbullushi, Samira Bell, Pablo Castro de la Nuez, Harijs Cernevskis, Cécile Couchoud, et al.
Pagina's: 182 - 195
- Should screening of renal markers be recommended in a working population?
Auteurs: Arjan van der Tol, Wim Van Biesen, Guy De Groote, Paul Verbeke, Frans Vermeiren, Kathleen Eeckhaut, Raymond Vanholder
Pagina's: 1601 - 1608